Our News
GlucoContro.online to be explored in upcoming Ascensia masterclass
A web-based solution that allows healthcare professionals to securely connect with their patients’ blood glucose readings will be the focus of an upcoming online session.
Fundraising campaign launched to enhance diabetes care in Sierra Leone
A national fundraising campaign to deliver essential diabetes resources to hospitals in Sierra Leone has been launched.
Places available for monogenic diabetes training course
Healthcare professionals are invited to sign up for a monogenic diabetes training course taking place later this year.
Don’t miss out on GlucoContro.online masterclass
There are only a few places left for a webinar on accessing reports via a web-based solution that allows healthcare professionals to connect with their patients’ blood glucose readings.
Endocrinology and diabetes board offer new opportunity to join the team
A respected endocrinology and diabetes committee is on the hunt for a new healthcare professional to become the latest member of its team.
NHS can now prescribe Wegovy® as part of “controlled and limited” launch
Wegovy® can now be prescribed to individuals living with, or at risk of, type 2 diabetes, as part of a controlled and limited launch.
DISN UK Group to host diabetes inpatient webinar
The past, present and future of diabetes inpatient nursing will be discussed during a webinar in November to mark World Diabetes Day.
Global diabetes award presented to Ipswich Hospital
An internationally recognised accolade has been awarded to a team at Ipswich Hospital for its outstanding integrated clinical care initiative for people with diabetes.
Applications open for diabetes ’Dragons’ Den’ funding scheme
Junior doctors and consultants wanting to carry out innovative research can now apply for funding through a new Dragons Den inspired scheme.
Last places available for diabetes GIRFT webinar
The impact of improving perioperative pathways for people with diabetes will be the subject of a webinar taking place next week.
Ascensia to hold third GlucoContro.online masterclass
Diabetes teams are invited to attend an online event next month to learn about a web-based solution that allows healthcare professionals to securely connect with their patients’ blood glucose readings seamlessly..
Registration now open for practical diabetes technology course in Leicester
A practical course targeted at healthcare professionals looking to improve their knowledge and confidence using diabetes technology is now open for registration.
Date set for Early-Career Physicians and Investigators Conference
Physicians starting out in their career can attend a conference exclusive for early careers next month.
Reproductive endocrinology to be at forefront of upcoming simulation-based learning event
Healthcare professionals with an interest in reproductive endocrinology are invited to attend a meeting dedicated to the topic next month.
Upcoming webinar to showcase specialist post-graduate diabetes training programme in Leicester
Healthcare professionals looking to specialise in diabetes care have been invited to join a webinar to learn about a part-time post graduate training programme dedicated to managing the condition in a webinar next month.
National clinician survey aims to ensure ‘consistent approach’ to reduce variations in diabetic footcare
Healthcare professionals working in footcare have been urged to complete an evaluation of local services as part of the drive to reduce variations in diabetic footcare across the country.
‘On the go’ diabetes education launched on Instagram
A new diabetes education service for healthcare professionals is now available on Instagram as part of a new project aiming to deliver “training on the go”.
Menarini becomes exclusive distributor for INVOKANA® (canagliflozin) and VOKANAMET® (fixed-dose combination of canagliflozin and metformin) in the UK
A. Menarini Farmaceutica Internazionale SRL (“Menarini”) has become the exclusive distributor for INVOKANA® (canagliflozin) and VOKANAMET® (a fixed-dose combination of canagliflozin and metformin) in the United Kingdom, including Northern Ireland, where the products have obtained Pricing and Reimbursement Approvals.
SGLT2 inhibitors are an ‘effective’ treatment option for heart failure and type 2 diabetes
Sodium-glucose Cotransporter-2 (SGLT2) inhibitors demonstrated robust clinical effectiveness in older adults with heart failure and type 2 diabetes, latest research shows.
Professor May Ng OBE to present esteemed Diabetes UK lecture
A leading diabetes consultant from Southport and Ormskirk Hospital has been chosen to deliver a prestigious national lecture in recognition of improvements she has delivered in patient care nationally and globally.